Targeting mir130b-IL-33-PD-L1 axis effectively inhibits esophageal squamous carcinoma progression
Ying Yue, Wei Xian, Yi Yuan, Xinyue Wang, Peng Wu, Xiaoyu Sha, Xiangyu Yue · 2026
Read Targeting mir130b-IL-33-PD-L1 axis effectively inhibits esophageal squamous carcinoma progression by Ying Yue, Wei Xian, Yi Yuan, Xinyue Wang, Peng Wu, Xiaoyu Sha, Xiangyu Yue (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13158390.txt.
Description
Ying Yue and six co-authors report a 2026 study on a signal chain that helps throat cancer grow and hide from the immune system. One link is a signal protein, IL-33, that is high in these tumors and tracks with late stage and poor outlook. Another link is the brake protein PD-L1, which tumors use to switch immune attacks off.
The team found that IL-33 raises PD-L1 and speeds tumor spread, and that blocking PD-L1 cuts the harm. A small RNA reins the chain in by silencing the switch that turns IL-33 on. Mice given more of that RNA grew smaller tumors with lower IL-33 and PD-L1. The two proteins also rose together across many cancer types. The authors name the chain a target for new treatment.
Catalog record
| CREATOR | Ying Yue, Wei Xian, Yi Yuan, Xinyue Wang, Peng Wu, Xiaoyu Sha, Xiangyu Yue |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |